ABBV vs MSFT
AbbVie Inc. vs Microsoft Corporation
ABBV
AbbVie Inc.
$208.37-0.30%
MSFT
Microsoft Corporation
$422.79+0.60%
Key Metrics Comparison
| ABBV | Metric | MSFT |
|---|---|---|
| $208.37 | Price | $422.79 |
| $368.56B | Market Cap | $3.14TBetter |
| 88.29 | P/E Ratio | 26.42Better |
| $2.36 | EPS | $16.00Better |
| -0.30% | Day Change | +0.60%Better |
| $244.81 | 52W High | $555.45 |
| $168.54 | 52W Low | $355.67 |
| 5,579,320 | Volume | 47,754,221Better |
| 7,057,350 | Avg Volume | 37,680,031Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...